Sustained population immunity from widespread vaccination and prior infections continues to limit the emergence of highly transmissible or severe SARS-CoV-2 strains, supporting traders' strong consensus on "No" for a new variant of concern before 2027. As of late April 2026, official monitoring bodies report no lineages meeting the formal criteria for variant of concern designation, with dominant circulating forms remaining Omicron sublineages such as XFG.1.1 and related strains. Recent attention on BA.3.2, a more mutated descendant first noted in late 2024, has shown immune-evasion traits and steady detections across dozens of countries, yet it has not produced higher hospitalization rates or rapid dominance that would trigger reclassification. Ongoing genomic surveillance and routine vaccine updates further reinforce this stability, with no major escalatory signals in the past several months.